CommercialAdministrativeLow impact
07.11.02f, Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders
Independence Blue Cross·Pulmonology, Allergy & Immunology, Family Medicine +2 more·Medical Policy
Effective date
Jan 22, 2025
We identified it
Jun 19, 2026
Summary
A reissued policy regarding measurement of exhaled nitric oxide and breath condensate for asthma and respiratory disorder diagnosis/management is now effective. This appears to be a routine policy reissue without substantive changes to coverage or billing requirements.
Action Required
By January 30, 2025: Billing team should review the full policy at the provided URL to confirm any changes to coverage criteria or documentation requirements for exhaled nitric oxide testing procedures. Update any relevant billing guidelines if changes are identified.